RxDoctor Payments Data

Martin Erickson, DO

Family Medicine · Livonia, MINPI 1326028523

Payments from drug & device makers

$11,786in general payments, 2019–2025

Across 780 payments — averaging $15.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Lilly USA, LLC$1K
  • Boehringer Ingelheim$996
  • AbbVie$795
  • GSK$650
  • AstraZeneca$587
  • plus $6K from 48 others

What the payments were for

  • Food & beverage$11,786100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,786 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$124,938
Medicare patients
199
Services billed
6,646

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide62$107,427
MounjaroTirzepatide64$87,492
JardianceEmpagliflozin57$74,999
EliquisApixaban61$70,308
XareltoRivaroxaban45$58,780
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$43,277
FarxigaDapagliflozin Propanediol23$30,264
TrulicityDulaglutide18$29,389
JanuviaSitagliptin Phosphate16$21,419
EntrestoSacubitril/Valsartan20$19,828
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog22$15,603
Lantus SolostarInsulin Glargine,hum.Rec.Anlog35$9,811
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$9,493
ShingrixVaricella-Zoster Ge/As01b/Pf28$6,119
Atorvastatin Calcium430$6,091

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,257$116,88182 claims
Novo NordiskOzempic$1,939$107,42762 claims
Boehringer IngelheimJardiance, Stiolto Respimat$996$84,49368 claims
PfizerEliquis$473$70,30861 claims
Johnson & JohnsonXarelto$500$58,78045 claims
GSKTrelegy Ellipta, Shingrix$650$49,39764 claims
AstraZenecaFarxiga, Symbicort$587$34,54336 claims
MerckJanuvia$502$21,41916 claims
NovartisEntresto$113$19,82820 claims
Teva Pharmaceuticals USA, Inc.Qvar Redihaler$422$3,19912 claims
AbbVieSynthroid$795$1,12120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Livonia

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →